# Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients

> **NCT03401749** · PHASE4 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 203 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Chlorhexidine Gluconate 2% Wipe
- **OTHER:** Theraworx Bath Wipes

## Key facts

- **NCT ID:** NCT03401749
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 203 (ACTUAL)
- **Why stopped:** Funding issues, poor recruiting and compliance of the patients.
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401749, "Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03401749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*